SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-029764
Filing Date
2021-05-25
Accepted
2021-05-25 16:08:12
Documents
56
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rain-10q_20210331.htm   iXBRL 10-Q 1461788
2 EX-31.1 rain-ex311_6.htm EX-31.1 20065
3 EX-31.2 rain-ex312_7.htm EX-31.2 20099
4 EX-32.1 rain-ex321_63.htm EX-32.1 12962
  Complete submission text file 0001564590-21-029764.txt   5392094

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rain-20210331.xsd EX-101.SCH 47359
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rain-20210331_cal.xml EX-101.CAL 32386
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rain-20210331_def.xml EX-101.DEF 152163
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rain-20210331_lab.xml EX-101.LAB 371797
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rain-20210331_pre.xml EX-101.PRE 272647
10 EXTRACTED XBRL INSTANCE DOCUMENT rain-10q_20210331_htm.xml XML 752519
Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560 (510) 953-5559
Rain Therapeutics Inc. (Filer) CIK: 0001724979 (see all company filings)

IRS No.: 821130967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40356 | Film No.: 21960669
SIC: 2834 Pharmaceutical Preparations